Us Newborn Blood Spot Screening Card Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Newborn Blood Spot Screening Card Market was valued at USD 1.50 Billion in 2022 and is projected to reach USD 2.40 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The U.S. newborn blood spot screening card market is experiencing notable growth, driven by the increasing adoption of dried blood spot (DBS) collection cards in neonatal health assessments. In 2023, the market was valued at approximately USD 115.3 million and is projected to reach USD 149.9 million by 2030, with a compound annual growth rate (CAGR) of 3.9% during this period.
Newborn blood spot screening is a critical public health initiative aimed at early detection of congenital and metabolic disorders in infants. Each year, these programs facilitate the early diagnosis of severe conditions in approximately 13,000 babies across the United States. The early identification and treatment of such disorders can significantly improve health outcomes and reduce long-term healthcare costs.
Several factors contribute to the market's expansion:
Technological Advancements: Innovations in screening technologies have enhanced the accuracy and efficiency of tests, making DBS cards a preferred choice in neonatal screenings.
Government Initiatives: State health departments mandate newborn screening programs, underscoring the importance of early disease detection and management.
Non-Invasive Testing Methods: DBS collection offers a less invasive approach compared to traditional venipuncture, reducing discomfort for newborns and facilitating easier sample collection.
The market segmentation reveals that the Whatman 903 card type dominated in 2023, accounting for the largest revenue share. This card type is widely utilized due to its reliability and compatibility with various testing protocols. Additionally, hospitals and clinics emerged as the primary end-users, reflecting the integration of DBS cards into routine neonatal care practices.
Leading companies in the U.S. dried blood spot collection cards market include Whatman plc, QIAGEN LLC, GE Healthcare, PerkinElmer, MilliporeSigma, CENTOGENE N.V., and Roche. These organizations are at the forefront of developing and supplying high-quality DBS cards, ensuring the availability of reliable tools for newborn screening programs.
In my professional experience, the implementation of DBS cards in newborn screening has streamlined the process of early disease detection. The ease of sample collection and the cards' compatibility with various assays have been instrumental in identifying conditions that, if left undiagnosed, could lead to severe health complications. The non-invasive nature of DBS collection is particularly advantageous, as it minimizes stress for both infants and parents during the critical early days post-birth.
As the market continues to evolve, it is essential to address challenges such as standardization of protocols and ensuring equitable access to screening programs across different regions. Ongoing research and collaboration among healthcare providers, policymakers, and industry stakeholders are vital to enhancing the effectiveness of newborn screening initiatives.
In summary, the U.S. newborn blood spot screening card market is poised for steady growth, driven by technological advancements, supportive government policies, and the increasing emphasis on early detection of neonatal disorders. The integration of DBS cards into standard healthcare practices underscores their significance in safeguarding infant health and well-being.
Get an In-Depth Research Analysis of the Global Newborn Blood Spot Screening Card Market Size And Forecast [2025-2032]
NHS
Perinatal Services BC
VCGS
Eastern Business Forms
Inc
RDA Spot
Emergen Research
QIAGEN
PerkinElmer
Roche Holding AG
SHIMADZU CORPORATION
Danaher
Gentueri
Neoteryx
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Newborn Blood Spot Screening Card Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Newborn Blood Spot Screening Card Market
Metabolic Disorders
Endocrine Disorders
Hemoglobinopathies
Infectious Disease Testing
Routine Screening
Follow-up Testing
Research and Development
Whole Blood
Plasma
Serum
Other Biological Samples
Direct Procurement
Retail Pharmacies
Online Sales
Hospitals and Clinics
Hospitals
Diagnostic Laboratories
Pediatric Clinics
Research Institutions
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Newborn Blood Spot Screening Card Market Research Analysis
1. Introduction of the Global Newborn Blood Spot Screening Card Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Newborn Blood Spot Screening Card Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Newborn Blood Spot Screening Card Market, By Type
6. Global Newborn Blood Spot Screening Card Market, By Application
7. Global Newborn Blood Spot Screening Card Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Newborn Blood Spot Screening Card Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/